健脾祛痰化瘀汤通过NOX1-ROS-ERK1/2通路改善动脉粥样硬化ApoE-/-小鼠内皮细胞氧化应激诱导的炎症反应

IF 6.7 1区 医学 Q1 CHEMISTRY, MEDICINAL
De Zhao Kong , Xue Zhi Zhang , Yi Lu , Yuan Yuan Zhou , Yi Hui Pan , Xin Qi Zhao , Xin Yu Wu , Wei Wei Li , Hui Ye
{"title":"健脾祛痰化瘀汤通过NOX1-ROS-ERK1/2通路改善动脉粥样硬化ApoE-/-小鼠内皮细胞氧化应激诱导的炎症反应","authors":"De Zhao Kong ,&nbsp;Xue Zhi Zhang ,&nbsp;Yi Lu ,&nbsp;Yuan Yuan Zhou ,&nbsp;Yi Hui Pan ,&nbsp;Xin Qi Zhao ,&nbsp;Xin Yu Wu ,&nbsp;Wei Wei Li ,&nbsp;Hui Ye","doi":"10.1016/j.phymed.2025.156815","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Atherosclerosis (AS) is a key mechanism in cardiovascular diseases and a major target for interventions. Jian-pi Qu-tan Hua-yu Decoction (JPQTHYD), a herbal formula, has been shown to alleviate AS.</div></div><div><h3>Objective</h3><div>This study aimed to evaluate the therapeutic effect of JPQTHYD on AS and explore its molecular mechanisms.</div></div><div><h3>Materials and Methods</h3><div>In vivo, we established a mouse model through a high-fat diet for 16 weeks combined with a 4-week exhaustive swimming experiment. The body weight and food intake of the mice were measured every 4 weeks. At the end of the 16 weeks, the moisture content of the mice's feces was measured, the morphology of the thoracic aorta and myocardium was observed using HE staining, and lipid deposition in the aorta and myocardium was assessed using Oil Red O staining. The ultrastructure of myocardial tissue was observed via transmission electron microscopy. Levels of TC, TG, and LDL-C were measured using an automatic biochemical analyzer. ELISA was used to detect the levels of ROS, IL-6, IL-10, TNF-α, hs-CRP, VCAM-1, and ICAM-1. In vitro, we induced HUVECs injury using 700 nM of Ang II. Cell viability was assessed using the CCK-8 assay, while ROS levels were measured by a ROS detection kit. NOX1 gene suppression was achieved using a NOX1 inhibitor. Protein expression levels of NOX1, ERK1/2, P-ERK1/2, VCAM-1, and ICAM-1 were measured by Western blot both in vivo and in vitro.</div></div><div><h3>Results</h3><div>1. JPQTHYD improved fecal water content and exercise capacity in ApoE-/- mice. 2. JPQTHYD reduced TC, TG, LDL-C levels, decreased arterial intimal thickness, and inhibited atherosclerotic plaque formation. 3. JPQTHYD decreased proinflammatory factors and adhesion molecules by inhibiting the NOX1-ROS-ERK1/2 pathway. 4. In vitro, JPQTHYD suppressed endothelial inflammation by reducing NOX1-ROS-ERK1/2 signaling.</div></div><div><h3>Conclusion</h3><div>JPQTHYD reduced blood lipids, inhibited oxidative stress-induced inflammation, and alleviated AS in ApoE-/- mice, likely through the NOX1-ROS-ERK1/2 pathway. This study offers a novel investigation into the mechanisms and regulatory pathways through which traditional Chinese medicine contributes to the prevention and treatment of atherosclerosis.</div></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"143 ","pages":"Article 156815"},"PeriodicalIF":6.7000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Jian-pi Qu-tan Hua-yu Decoction improves oxidative stress-induced inflammation in endothelial cells in atherosclerotic ApoE-/- mice through the NOX1-ROS-ERK1/2 pathway\",\"authors\":\"De Zhao Kong ,&nbsp;Xue Zhi Zhang ,&nbsp;Yi Lu ,&nbsp;Yuan Yuan Zhou ,&nbsp;Yi Hui Pan ,&nbsp;Xin Qi Zhao ,&nbsp;Xin Yu Wu ,&nbsp;Wei Wei Li ,&nbsp;Hui Ye\",\"doi\":\"10.1016/j.phymed.2025.156815\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Atherosclerosis (AS) is a key mechanism in cardiovascular diseases and a major target for interventions. Jian-pi Qu-tan Hua-yu Decoction (JPQTHYD), a herbal formula, has been shown to alleviate AS.</div></div><div><h3>Objective</h3><div>This study aimed to evaluate the therapeutic effect of JPQTHYD on AS and explore its molecular mechanisms.</div></div><div><h3>Materials and Methods</h3><div>In vivo, we established a mouse model through a high-fat diet for 16 weeks combined with a 4-week exhaustive swimming experiment. The body weight and food intake of the mice were measured every 4 weeks. At the end of the 16 weeks, the moisture content of the mice's feces was measured, the morphology of the thoracic aorta and myocardium was observed using HE staining, and lipid deposition in the aorta and myocardium was assessed using Oil Red O staining. The ultrastructure of myocardial tissue was observed via transmission electron microscopy. Levels of TC, TG, and LDL-C were measured using an automatic biochemical analyzer. ELISA was used to detect the levels of ROS, IL-6, IL-10, TNF-α, hs-CRP, VCAM-1, and ICAM-1. In vitro, we induced HUVECs injury using 700 nM of Ang II. Cell viability was assessed using the CCK-8 assay, while ROS levels were measured by a ROS detection kit. NOX1 gene suppression was achieved using a NOX1 inhibitor. Protein expression levels of NOX1, ERK1/2, P-ERK1/2, VCAM-1, and ICAM-1 were measured by Western blot both in vivo and in vitro.</div></div><div><h3>Results</h3><div>1. JPQTHYD improved fecal water content and exercise capacity in ApoE-/- mice. 2. JPQTHYD reduced TC, TG, LDL-C levels, decreased arterial intimal thickness, and inhibited atherosclerotic plaque formation. 3. JPQTHYD decreased proinflammatory factors and adhesion molecules by inhibiting the NOX1-ROS-ERK1/2 pathway. 4. In vitro, JPQTHYD suppressed endothelial inflammation by reducing NOX1-ROS-ERK1/2 signaling.</div></div><div><h3>Conclusion</h3><div>JPQTHYD reduced blood lipids, inhibited oxidative stress-induced inflammation, and alleviated AS in ApoE-/- mice, likely through the NOX1-ROS-ERK1/2 pathway. This study offers a novel investigation into the mechanisms and regulatory pathways through which traditional Chinese medicine contributes to the prevention and treatment of atherosclerosis.</div></div>\",\"PeriodicalId\":20212,\"journal\":{\"name\":\"Phytomedicine\",\"volume\":\"143 \",\"pages\":\"Article 156815\"},\"PeriodicalIF\":6.7000,\"publicationDate\":\"2025-05-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Phytomedicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0944711325004532\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytomedicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0944711325004532","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

动脉粥样硬化(AS)是心血管疾病的重要机制,也是干预的主要目标。健脾祛痰化瘀汤(JPQTHYD)是一种具有缓解AS作用的中药配方。目的评价JPQTHYD对AS的治疗作用,探讨其分子机制。材料与方法在体内,通过16周高脂饮食结合4周力竭游泳实验建立小鼠模型。每4周测量小鼠的体重和摄食量。16周结束时,测定小鼠粪便含水率,HE染色观察胸主动脉及心肌形态,油红O染色观察主动脉及心肌脂质沉积。透射电镜观察心肌组织超微结构。使用自动生化分析仪测量TC、TG和LDL-C水平。ELISA法检测各组ROS、IL-6、IL-10、TNF-α、hs-CRP、VCAM-1、ICAM-1水平。在体外,我们用700 nM的Ang II诱导HUVECs损伤。采用CCK-8法评估细胞活力,采用ROS检测试剂盒检测ROS水平。使用NOX1抑制剂实现NOX1基因抑制。Western blot法检测体内外组织中NOX1、ERK1/2、P-ERK1/2、VCAM-1、ICAM-1蛋白表达水平。JPQTHYD提高了ApoE-/-小鼠的粪便含水量和运动能力。2. JPQTHYD降低TC、TG、LDL-C水平,降低动脉内膜厚度,抑制动脉粥样硬化斑块形成。3. JPQTHYD通过抑制NOX1-ROS-ERK1/2通路降低促炎因子和粘附分子。4. 在体外,JPQTHYD通过降低NOX1-ROS-ERK1/2信号通路抑制内皮细胞炎症。结论jpqthyd可能通过NOX1-ROS-ERK1/2通路降低ApoE-/-小鼠血脂,抑制氧化应激性炎症,减轻AS。本研究为中医药预防和治疗动脉粥样硬化的机制和调控途径提供了新的探索。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Jian-pi Qu-tan Hua-yu Decoction improves oxidative stress-induced inflammation in endothelial cells in atherosclerotic ApoE-/- mice through the NOX1-ROS-ERK1/2 pathway

Background

Atherosclerosis (AS) is a key mechanism in cardiovascular diseases and a major target for interventions. Jian-pi Qu-tan Hua-yu Decoction (JPQTHYD), a herbal formula, has been shown to alleviate AS.

Objective

This study aimed to evaluate the therapeutic effect of JPQTHYD on AS and explore its molecular mechanisms.

Materials and Methods

In vivo, we established a mouse model through a high-fat diet for 16 weeks combined with a 4-week exhaustive swimming experiment. The body weight and food intake of the mice were measured every 4 weeks. At the end of the 16 weeks, the moisture content of the mice's feces was measured, the morphology of the thoracic aorta and myocardium was observed using HE staining, and lipid deposition in the aorta and myocardium was assessed using Oil Red O staining. The ultrastructure of myocardial tissue was observed via transmission electron microscopy. Levels of TC, TG, and LDL-C were measured using an automatic biochemical analyzer. ELISA was used to detect the levels of ROS, IL-6, IL-10, TNF-α, hs-CRP, VCAM-1, and ICAM-1. In vitro, we induced HUVECs injury using 700 nM of Ang II. Cell viability was assessed using the CCK-8 assay, while ROS levels were measured by a ROS detection kit. NOX1 gene suppression was achieved using a NOX1 inhibitor. Protein expression levels of NOX1, ERK1/2, P-ERK1/2, VCAM-1, and ICAM-1 were measured by Western blot both in vivo and in vitro.

Results

1. JPQTHYD improved fecal water content and exercise capacity in ApoE-/- mice. 2. JPQTHYD reduced TC, TG, LDL-C levels, decreased arterial intimal thickness, and inhibited atherosclerotic plaque formation. 3. JPQTHYD decreased proinflammatory factors and adhesion molecules by inhibiting the NOX1-ROS-ERK1/2 pathway. 4. In vitro, JPQTHYD suppressed endothelial inflammation by reducing NOX1-ROS-ERK1/2 signaling.

Conclusion

JPQTHYD reduced blood lipids, inhibited oxidative stress-induced inflammation, and alleviated AS in ApoE-/- mice, likely through the NOX1-ROS-ERK1/2 pathway. This study offers a novel investigation into the mechanisms and regulatory pathways through which traditional Chinese medicine contributes to the prevention and treatment of atherosclerosis.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Phytomedicine
Phytomedicine 医学-药学
CiteScore
10.30
自引率
5.10%
发文量
670
审稿时长
91 days
期刊介绍: Phytomedicine is a therapy-oriented journal that publishes innovative studies on the efficacy, safety, quality, and mechanisms of action of specified plant extracts, phytopharmaceuticals, and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of herbal medicinal products, preparations, and purified compounds with defined and consistent quality, ensuring reproducible pharmacological activity. Founded in 1994, Phytomedicine aims to focus and stimulate research in this field and establish internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy, and safety of phytomedicines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信